NAGA Breaks New Ground: Unveils First-Ever Trading App Integrated into Telegram Messenger

In a bold move that could redefine how retail investors engage with financial markets, NAGA has launched the world’s first fully integrated trading app within Telegram, tapping into the messaging platform’s 950 million-strong user base. This pioneering step positions NAGA as the first to offer seamless access to financial markets directly within Telegram’s App Center, […]

GlamAI Launches Virtual Try-On for Fashion Retailers

SAN FRANCISCO, CA / ACCESSWIRE / September 19, 2024 / Today, at Paris Retail Week, GlamAI is unveiling its cutting-edge digital fitting room solution for fashion eCommerce companies. This marks the first public showcase of their AI-powered Virtual Try-On technology, designed to revolutionize the online shopping experience for fashion retailers. GlamAI’ Virtual Try-On bridges the

Guidehouse Insights Estimates 7% of Long-Haul Trucks Will be Electric by 2033

Market barriers include purchase price, infrastructure, and scarcity of production capacity A new report from Guidehouse Insightsexplores the landscape for long-haul truck electrification in the US. https://mma.prnewswire.com/media/1653427/Guidehouse_Insights_Logo.jpg Industry experts expect long-haul trucks to be among the last automotive sectors to electrify due to their high purchase cost and the lack of available charging infrastructure. According

White Castle levels up loyalty program, “Craver NationĀ® Rewards,” bringing high-value perks, points and rewards for members

Craver Nation Rewards is the perfect app to order the $7.99 Cheesy 10 Sack deal and satisfy a late night Crave White Castle has given its customer loyalty program a revamp, and the iconic family-owned Slider chain is excited to see how its customers respond. https://mma.prnewswire.com/media/2509081/White_Castle_CraverNation.jpg White Castle releases Craver Nation Rewards, an updated version

Experts estimate modest drop in 2023 emissions, with big differences across sectors

Canadian Climate Institute’s Early Estimate of National Emissions shows a drop of about 1 per cent in 2023, with Canada’s emissions now 8 per cent lower than 2005 levels. The latest Early Estimate of National Emissions(EENE) from the Canadian Climate Institute shows a modest improvement in national emissions in 2023, with a drop of about

Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology

Sirnaomics Ltd. (the “Company”, Stock Code: 2257, together with its subsidiaries,the “Group” or “Sirnaomics”), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the company in collaboration with Dr. Mark Nestor’s team from the Center for Clinical and Cosmetic Research in Miami Florida has jointly published a major

TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide

New messaging reflects TFS’s commitment to patient-centered clinical research and global partnerships TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), proudly announces the launch of its new mission statement and tagline: Empowering Partners. Enriching Lives. This strategic shift underscores TFS’s commitment to advancing clinical research, improving patient outcomes, and fostering sustainable partnerships. The

ITM to Present at Upcoming Radiopharmaceutical Investor Conferences in New York City

Garching / Munich, September 19, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry investor conferences in New York City. ITM’s Chief Executive Officer, Dr. Andrew Cavey will deliver corporate presentations and participate in panel discussions, highlighting the Company’s broad, targeted radiopharmaceutical pipeline,

Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology

Sirnaomics Ltd. (the “Company”, Stock Code: 2257, together with its subsidiaries,the “Group” or “Sirnaomics”), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the company in collaboration with Dr. Mark Nestor’s team from the Center for Clinical and Cosmetic Research in Miami Florida has jointly published a major

Everads Presents Clinical Data from First-in-Human Trial of Suprachoroidal Delivery Technology at EURETINA

1st cohort data demonstrates safety, feasibility and tolerability of the Everads Injector for delivering drugs to the back of the eye via thesuprachoroidal space Results validate use of the Injector in a clinical, office-based setting, and will supportthe clinical trial applications of Everads’ gene therapy license partners Everads Therapy,a clinical stage biotechnology company developing a

Scroll to Top